Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Phone number
Website URL
Similar Companies999
Sucampo Pharmaceuticals
Sucampo is a biopharmaceutical company that develops and commercializes specialized medicines for unmet medical needs.
Sector
Subsector
Keywords
Location
total rounds
total raised
Shield Therapeutics
Shield Therapeutics is a pharmaceutical company developing and commercializing late-stage, mineral-derived pharmaceuticals.
Sector
Subsector
Location
total rounds
total raised
ViroPharma
ViroPharma is a biopharmaceutical company that develops and commercializes products for serious diseases.
Sector
Subsector
Keywords
Location
total rounds
Millennium Pharmaceuticals
Millennium Pharmaceuticals is a biopharmaceutical company that develops and commercializes cancer medicines.
Sector
Subsector
Keywords
Location
total rounds
M&A Details1
Transaction name
Acquired by
Johnson & Johnson
announced date
price
Financials
Funding Rounds1
Number of Funding Rounds
Money Raised
Their latest funding was raised on 01.05.1998. Their latest investor Reference Capital SA. Their latest round Venture - Series Unknown
Reference Capital SA
Reference Capital is a Swiss private investments advisor for European families.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Atlas Venture
Atlas Venture invests in biotech startups with seed and early stage venture investments.
Sector
Subsector
Keywords
Location
total rounds
count Of Investments
count Of Exists
Sofinnova Investments
Sofinnova Investments is a venture capital firm that specializes in funding and supporting Life Science and Technology start-ups.
Sector
Subsector
Location
count Of Investments
count Of Exists
Co-Investors
Investors4
Number of lead investors
Number of investors
Reference Capital SA
Reference Capital is a Swiss private investments advisor for European families.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
HealthCap
HealthCap is a venture capital firm that invests in life sciences globally.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Atlas Venture
Atlas Venture invests in biotech startups with seed and early stage venture investments.
Sector
Subsector
Keywords
Location
total rounds
count Of Investments
count Of Exists
Acquisitions3
Ceptaris Therapeutics acquired by Actelion Pharmaceuticals
acquirer
date
type
price
Ceptaris Therapeutics
Ceptaris Therapeutics is a pharmaceutical company developing therapeutics for early-stage mycosis fungoides.
Sector
Subsector
Keywords
Location
total rounds
total raised
Cotherix acquired by Actelion Pharmaceuticals
acquirer
date
type
price
Cotherix
CoTherix develops biopharmaceutical products for chronic diseases.
Sector
Subsector
Location
total rounds
total raised
Axovan acquired by Actelion Pharmaceuticals
acquirer
date
type
Axovan
Axovan AG is a Swiss drug development company that specializes in G Protein-Coupled Receptors.
Sector
Subsector
Keywords
Location
total rounds
total raised
People
Founders4
Jean-Paul Clozel
Jean-Paul Clozel is the CEO at Idorsia.
current job
count Of Investments
Jean-Paul Clozel
Walter Fischli
Dr. Walter Fischli was educated as a biochemist at the Swiss Institute of Technology (ETH) Zurich, with further training at the Addiction Research Foundation/Stanford University in Palo Alto, USA. During his subsequent 15 years at F. Hoffmann-La Roche Ltd, he worked in research and led various drug discovery projects. In 1993 he received the Hoffmann-La Roche Research Prize. In 1997, Walter co-founded Actelion Pharmaceuticals Ltd, where he built up the Biology department and complemented the other two drug discovery departments around Medicinal Chemistry and Pharmacology headed by Thomas Weller and Martine Clozel, respectively. In Mid 2009 he handed over his position to Beat Steiner and served as Senior Vice President, for Academia Relations until his retirement at the end of 2012.
current job
organization founded
Walter Fischli
Thomas Widmann
A cardiologist educated at Heidelberg and Paris in Medicine and Computer Science with further training at the University Hospital in Geneva, Thomas Widmann later spent seven years at the University of California, San Diego, as Assistant Professor of Medicine and Cardiovascular Associate. During his nine years at F. Hoffmann-La Roche, he was responsible for the worldwide clinical development of the company's cardiovascular portfolio, which included eight large projects at various stages of development (Phase I to NDA). He was chairman of F. Hoffmann-La Roche's cardiovascular strategy team and led an international cardiovascular development team of over 60 people in Europe and the US. In 1996, he founded Hesperion, a company that focuses on clinical development and consulting. Due to his continuing interest in strategic R&D and other management topics, he has also attended business courses at INSEAD. As founding member of Actelion, he was Actelion`s first Chief Executive Officer and then held the position of Vice Chairman of the Board until spring 2003. Tom continues to work in close association with the Actelion senior management.
current job
Thomas Widmann
André J. Mueller
With two degrees in Chemical Engineering and Business Administration from INSEAD, André Mueller started his career with CIBA Ltd and Sandoz (now Novartis), where he held a number of managerial positions in the strategic planning and finance divisions both at headquarters and in the US.After seven years with Sandoz, André moved to Biogen, becoming VP of Finance and Administration and then CFO. As CFO he was responsible for several financing rounds, including Biogen's IPO. Four years later, he became a Founding Partner and Director of Investments for Genevest, the first Swiss venture capital organization.In 1997, André was a member of the founding team of Actelion and served as CFO until 2003.
current job
count Of Investments
count Of Exists
André J. Mueller
Employee Profiles301
Susan Wu
Executive assistant, head of legal, hcc officer and regulatory leaders
Andrea Galli
Global director customer engagement excellence